GlassScriptPhysician profile
Benjamin D Blossom
NPI 1477648087
$6,583.77
in general payments reported to CMS, 2019-2025
36 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $649 · 2020: $455 · 2021: $577 · 2022: $777 · 2023: $1,453 · 2024: $1,374 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,125.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,005.89 | 2022-2025 | Onyx Frontier, Symplicity G3, Ffrangio |
| Abiomed | $959.39 | 2019-2025 | Impella |
| Abbott Laboratories | $481.01 | 2019-2025 | Xience Sierra, Navitor |
| Merck Sharp & Dohme LLC | $387.09 | 2021-2024 | Verquvo |
| Penumbra, INC. | $376.33 | 2022-2025 | Indigo System |
| Cook Medical LLC | $322.21 | 2019-2024 | Zilver Ptx |
| Boston Scientific Corporation | $291.68 | 2020-2025 | General - Vascular Intervention, Ekosonic |
| E.R. Squibb & Sons, L.L.C. | $231.69 | 2024-2025 | Camzyos, Eliquis |
| Angiodynamics, INC. | $224.12 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $223.75 | 2019-2023 | Farxiga |
| Thrombolex, INC. | $187.68 | 2024-2025 | Bashir Endovascular Catheter |
| Inari Medical, INC. | $187.23 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $127.77 | 2021-2025 | |
| Livanova USA, INC. | $125.67 | 2021 | |
| Biotronik INC. | $100.30 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $99.88 | 2023-2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Ekos Corporation | $98.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $97.31 | 2019-2025 | |
| Terumo Medical Corporation | $94.43 | 2022-2025 | Angio-Seal |
| Amgen INC. | $89.92 | 2020-2025 | Repatha, Repatha |
| Novo Nordisk INC | $80.04 | 2023-2024 | Wegovy |
| Janssen Scientific Affairs, LLC | $79.96 | 2019 | |
| Bard Peripheral Vascular, INC. | $76.87 | 2023-2024 | Lutonix Drug Coated Balloon |
| Sanofi-Aventis U.S. LLC | $71.89 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $69.35 | 2023-2025 | Amvuttra, Onpattro |
| Philips North America LLC | $69.16 | 2025 | Coronary Other |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.90 | 2022 | |
| Cardiva Medical, INC. | $60.85 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Edwards Lifesciences Corporation | $56.92 | 2025 | Sapien 3 Ultra Resilia |
| Amarin Pharma, INC. | $56.15 | 2019-2021 | |
| Daxor Corporation | $49.69 | 2023 | Bva-100 |
| Janssen Pharmaceuticals, INC | $45.82 | 2021-2023 | Xarelto |
| Astellas Pharma US INC | $38.51 | 2019-2022 | |
| Atricure, INC. | $35.73 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.35 | 2025 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Blossom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.